Investigational Drug Information for Nepicastat
✉ Email this page to a colleague
« Back to Dashboard
▶ Start for $1
Remove trial restrictions
What is the development status for investigational drug Nepicastat?
Nepicastat is an investigational drug.
There have been 5 clinical trials for Nepicastat. The most recent clinical trial was a Phase 2 trial, which was initiated on April 1st 2013.
The most common disease conditions in clinical trials are Cocaine-Related Disorders, Stress Disorders, Traumatic, and Stress Disorders, Post-Traumatic. The leading clinical trial sponsors are Biotie Therapies Inc., National Institute on Drug Abuse (NIDA), and Acorda Therapeutics.
Summary for Nepicastat
|US Patent Applications||183|
|WIPO Patent Applications||73|
|Japanese Patent Applications||38|
|Clinical Trial Progress||Phase 2 (2013-04-01)|
Recent Clinical Trials for Nepicastat
|A Phase 1b Study to Evaluate APL-1401 in Patients With Moderately to Severely Active Ulcerative Colitis||Jiangsu Yahong Meditech Co., Ltd aka Asieris||Phase 1|
|A Multi-Center Trial of Nepicastat for Cocaine Dependence||National Institute on Drug Abuse (NIDA)||Phase 2|
|Nepicastat for Posttraumatic Stress Disorder (PTSD) in OIF/OEF Veterans||Acorda Therapeutics||Phase 2|
Clinical Trial Summary for Nepicastat
Top disease conditions for Nepicastat
Top clinical trial sponsors for Nepicastat
US Patents for Nepicastat
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|